By using this site, you agree to the Privacy Policy
Accept
Sign In
The Board Room LeadersThe Board Room Leaders
Notification
Font ResizerAa
  • News
    NewsShow More
    Lys Therapeutics funding
    Lys Therapeutics Raises Over €25 Million to Advance Neurology Drug Into Human Trials
    3 days ago
    Cortea €12M Seed Funding
    Cortea Raises €12 Million Seed Funding to Strengthen AI-Powered Audit Reviews
    7 days ago
    Soource Maicol Verzotto
    Soource Raises €3 Million in Seed Funding to Advance AI-Powered Procurement Solutions
    1 week ago
    RealTime Reservation acquires STAY
    RealTime Reservation Acquires STAY to Expand Global Guest Experience Platform
    2 weeks ago
    Mendo Raises €12 Million Series A Funding
    Mendo Raises €12 Million Series A Funding to Speed Up AI Adoption Across Europe
    2 weeks ago
  • Featured
    FeaturedShow More
    Andres Garcia-Amaya, Founder & CEO of Zoe Financial.
    Inside the Strategic Vision of Andres Garcia-Amaya, Founder & CEO, Zoe Financial.
    6 days ago
    Colin Falls, CEO of GeoWealth
    From the Back Office to the Executive Suite: Colin Falls and the Evolution of GeoWealth
    6 days ago
    Snehal Fulzele, founder and CEO of UPTIQ
    Beyond the Sandbox: Snehal Fulzele and the $55M Quest to Scale UPTIQ in Regulated Finance
    6 days ago
    Peter Wells, CEO of TemperPack
    Peter Wells & TemperPack: Replacing Styrofoam with Bio-Based Packaging
    2 weeks ago
    saloni-doshi-ecoenclose
    Inside EcoEnclose: How CEO Saloni Doshi Built an E-Commerce Sustainability Empire
    2 weeks ago
  • Industry
    IndustryShow More
    Semiconductor Independence
    Semiconductor Independence: Why Every Country Is Fighting for Chip Sovereignty
    2 months ago
    Spirit Airlines Shutdown
    Spirit Airlines Shutdown: The Full Story Behind the Collapse
    2 months ago
    Chinese EV threat to European carmakers
    Chinese EV Threat to European Carmakers: Why the Fear Is Justified
    2 months ago
    Social Media Security
    Advanced Social Media Security: A Practical Guide to Minimizing Personal Data Exposure in 2026
    3 months ago
    AI’s New Geopolitical Battlefield: The OpenAI–Anthropic Pentagon Controversy
    4 months ago
  • Opinion
  • Industry
    IndustryShow More
    Semiconductor Independence
    Semiconductor Independence: Why Every Country Is Fighting for Chip Sovereignty
    2 months ago
    Spirit Airlines Shutdown
    Spirit Airlines Shutdown: The Full Story Behind the Collapse
    2 months ago
    Chinese EV threat to European carmakers
    Chinese EV Threat to European Carmakers: Why the Fear Is Justified
    2 months ago
    Social Media Security
    Advanced Social Media Security: A Practical Guide to Minimizing Personal Data Exposure in 2026
    3 months ago
    AI’s New Geopolitical Battlefield: The OpenAI–Anthropic Pentagon Controversy
    4 months ago
  • Start Ups
    Start UpsShow More
    Elon Musk Cursor deal
    Elon Musk’s $60 Billion Cursor Deal Could Redefine the Coding AI Market
    2 months ago
    Lifestyle Startup Ideas You Can Launch With Minimal Investment
    10 Profitable Lifestyle Startup Ideas You Can Launch With Minimal Investment
    1 year ago
    The Rise of Personalized Nutrition Startups
    The Rise of Personalized Nutrition Startups: Tailoring Health to You
    1 year ago
    How to Choose the Right E-commerce Platform for Your Start-Up?
    How to Choose the Right E-commerce Platform for Your Start-Up?
    1 year ago
    How to Create a Startup Culture That Attracts Top Talent
    How to Create a Startup Culture That Attracts Top Talent
    1 year ago
  • Economy
  • Be An Author
Reading: Suvoda’s Jagath Wanninayake Built a Clinical Trials Empire from Scratch
Share
The Board Room LeadersThe Board Room Leaders
Font ResizerAa
Search
  • My Bookmarks
  • Featured
  • Start Ups
  • Industry
  • Cookie Policy
  • Contact Us
Have an existing account? Sign In
Follow US
  • Advertise
© 2026 Adaptica Solutions. All Rights Reserved.
The Board Room Leaders > Blog > Featured > Suvoda’s Jagath Wanninayake Built a Clinical Trials Empire from Scratch
Featured

Suvoda’s Jagath Wanninayake Built a Clinical Trials Empire from Scratch

Stella Young
Last updated: 2026/04/13 at 9:31 AM
Stella Young
Share
Suvoda
The Boardroom Leader
SHARE

Suvoda’s Co‑Founder, Chairman & CEO and the face of powerful leadership in clinical‑trial technology Jagath Wanninayake has charted an impressive entrepreneurial journey marked by innovation, strategic commitment, and authentic vision. Based in Greater Philadelphia, his leadership continues reshaping how clinical trials are managed worldwide.

Contents
Early Life and EducationFrom Clarix to Suvoda: A Legacy of Visionary ScalingAwards & RecognitionLeadership Anchored in PurposeA Forward-Looking Leadership StyleAcademic & Early BackgroundWhy “Suvoda’s” powerful leadership matters:

Early Life and Education

Jagath Wanninayake was born and raised in Sri Lanka before moving to the United States for higher education. From a young age, he exhibited a keen interest in problem-solving and systems thinking traits that would later define his entrepreneurial journey. He pursued his undergraduate studies at Swarthmore College, one of the most prestigious liberal arts institutions in the U.S., where he earned a Bachelor of Arts in Economics with a concentration in Public Policy. This academic foundation gave him a unique lens into both the macroeconomic and regulatory forces shaping the healthcare and technology industries. His time at Swarthmore helped sharpen his analytical skills and his passion for innovation, social impact, and strategic leadership, setting the stage for his future ventures in clinical trial technology.

From Clarix to Suvoda: A Legacy of Visionary Scaling

Jagath began his journey by co‑founding Clarix LLC, where he led development of the first fully web‑integrated randomization and trial supply management system, setting a new industry benchmark in deployment speed. Over six years, Clarix expanded from a three‑person startup to a 100‑person multinational, serving three of the top five and 11 of the top 25 pharmaceutical companies globally. Under his leadership, Clarix enjoyed triple‑digit annual revenue growth and over 95% client retention, ultimately leading to acquisition by Phase Forward (now Oracle).

Transitioning from Clarix, Jagath then co‑founded  Suvodain 2012 alongside Robert Hummel. Since then, Suvoda has grown into a series C company with more than 300 employees as of late 2022. Headquartered in Conshohocken, PA, the company has built powerful clinical-trial management platforms like IRT, eConsent, eCOA, and ePatient supporting 1,500+ trials across 95+ countries.

Awards & Recognition

In 2017, Jagath earned the prestigious EY Entrepreneur of the Year award for Greater Philadelphia, recognized for leading Suvoda from a six‑person startup to a multinational operation within four years all without outside funding.

Leadership Anchored in Purpose

The term “Suvoda” from Sanskrit meaning “the dawn of well‑being” reflects the deep purpose behind Jagath’s work to ease the complexity of clinical trials and bring life‑saving treatments to patients faster and safer. He also serves on the board of the Eastern PA Chapter of the Leukemia & Lymphoma Society and acts as an active mentor and angel investor for tech startups.

A Forward-Looking Leadership Style

Jagath emphasizes balanced innovation. In a 2024 conversation, he noted how the industry is shifting from idealizing fully virtual trials to embracing hybrid models that blend digital and in-person designs for better accessibility and effectiveness . He also highlighted the growing role of AI in accelerating drug development and simulation, while stressing the need for human oversight to ensure safety, ethics, and accuracy.

Academic & Early Background

Jagath holds a B.A. in economics with a concentration in public policy from Swarthmore College. He began his career in venture capital, focusing on enterprise software and telecommunications before launching Clarix.

Why “Suvoda’s” powerful leadership matters:

  • Suvoda underscores his commitment not to innovation for its own sake, but to delivering tools that make complex clinical trials manageable and meaningful.
  • Suvoda aligns with his personal journey from clinician tech pioneer at Clarix to a guiding voice in modern, hybrid, AI-informed trial design.
  • Suvoda embodies his entrepreneurial spirit, community focus, and the tangible impact of his leadership on improving trial delivery and patient outcomes.

In a landscape of healthcare innovation, Suvoda’s Jagath Wanninayake stands out not as a distant tech CEO, but as a powerful leader driven by clarity of purpose, grounded human oversight, and a record of real-world execution.

Stella Young
+ postsBio ⮌
  • Stella Young
    Lys Therapeutics Raises Over €25 Million to Advance Neurology Drug Into Human Trials
  • Stella Young
    Cortea Raises €12 Million Seed Funding to Strengthen AI-Powered Audit Reviews
  • Stella Young
    Soource Raises €3 Million in Seed Funding to Advance AI-Powered Procurement Solutions
  • Stella Young
    RealTime Reservation Acquires STAY to Expand Global Guest Experience Platform

You Might Also Like

Inside the Strategic Vision of Andres Garcia-Amaya, Founder & CEO, Zoe Financial.

From the Back Office to the Executive Suite: Colin Falls and the Evolution of GeoWealth

Beyond the Sandbox: Snehal Fulzele and the $55M Quest to Scale UPTIQ in Regulated Finance

Peter Wells & TemperPack: Replacing Styrofoam with Bio-Based Packaging

Inside EcoEnclose: How CEO Saloni Doshi Built an E-Commerce Sustainability Empire

Sign Up For Monthly Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
Please enable JavaScript in your browser to complete this form.
Loading
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Previous Article health and wellness trends 2025 Health Hacks to Thrive in 2025: Wellness Trends Unveiled
Next Article Lyra Health's Connie Chen Lyra Health’s Connie Chen: Transforming Mental Health Through Visionary Leadership and Clinical Innovation

Next To Read

Lys Therapeutics funding
Lys Therapeutics Raises Over €25 Million to Advance Neurology Drug Into Human Trials
News
Andres Garcia-Amaya, Founder & CEO of Zoe Financial.
Inside the Strategic Vision of Andres Garcia-Amaya, Founder & CEO, Zoe Financial.
Featured
Colin Falls, CEO of GeoWealth
From the Back Office to the Executive Suite: Colin Falls and the Evolution of GeoWealth
Featured
Snehal Fulzele, founder and CEO of UPTIQ
Beyond the Sandbox: Snehal Fulzele and the $55M Quest to Scale UPTIQ in Regulated Finance
Featured
When to Avoid AI The Cases That Changed the Law
When to Avoid AI: The Cases That Cost People Everything
Opinion
The Board Room Leaders

The Boardroom Leaders is a premier news platform delivering breaking stories, insights, and analysis on business, technology, startups, and leadership, spotlighting corporate giants and innovative disruptors.

COMPANY

About Us
Contact

Insight

Featured
Technology
Business

Legal

Privacy Policy
Term Of Services
Cookie Policy

The Board Room Leaders © 2026 BuzzCraze Media Group

Follow US
© The Boardroom Leaders Media Company. All Rights Reserved.
Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

Please enable JavaScript in your browser to complete this form.
Loading
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?